This page lists the SEC filings reported by Pharmstandard International S.A..
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G | 2018-11-15 | Pharmstandard International S.A. | Allena Pharmaceuticals, Inc. | 873,031 | 4.2% | EDGAR |
SC 13G/A | 2018-02-21 | Pharmstandard International S.A. | Protagonist Therapeutics, Inc | 982,270 | 4.8% | EDGAR |
SC 13G | 2018-02-15 | Pharmstandard International S.A. | Allena Pharmaceuticals, Inc. | 1,037,267 | 5.0% | EDGAR |
SC 13D/A | 2017-06-26 | Pharmstandard International S.A. | ARGOS THERAPEUTICS INC | 18,362,883 | 39.9% | EDGAR |
SC 13G | 2017-02-13 | Pharmstandard International S.A. | Protagonist Therapeutics, Inc | 983,570 | 5.9% | EDGAR |
SC 13D/A | 2016-10-18 | Pharmstandard International S.A. | ARGOS THERAPEUTICS INC | 18,362,883 | 39.6% | EDGAR |
SC 13D/A | 2016-08-18 | Pharmstandard International S.A. | ARGOS THERAPEUTICS INC | 17,931,624 | 38.7% | EDGAR |
SC 13D/A | 2016-07-12 | Pharmstandard International S.A. | ARGOS THERAPEUTICS INC | 13,795,261 | 41.3% | EDGAR |
SC 13D/A | 2016-05-27 | Pharmstandard International S.A. | ARGOS THERAPEUTICS INC | - | - | EDGAR |
SC 13D | 2016-03-22 | Pharmstandard International S.A. | ARGOS THERAPEUTICS INC | 9,108,234 | 34.2% | EDGAR |
SC 13G | 2015-02-12 | Pharmstandard International S.A. | PROTEON THERAPEUTICS INC | 1,165,344 | 7.1% | EDGAR |
SC 13G | 2015-02-12 | Pharmstandard International S.A. | ARGOS THERAPEUTICS INC | 5,983,549 | 30.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.